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ABSTRACT

Longitudinal tracking and accumulation of polymeric nanoparticles in the context
of cancer has largely occurred through identification of a fluorescent cargo. In this study,
we created a dual extracellular acidic pH targeted polypyrrole-based hollow nanoparticle
as a theranostic (maintain both therapeutic and diagnostic capabilities) agent for improved
detection and treatment of ovarian cancer. Polypyrrole-hollow nanospheres (PPy-CS)
were fabricated through the removal of a silver chloride (AgCl) core, which served as a
template, followed by coating with chitosan and further tumor targeted with a pH low
insertion peptide, V7. We exploited the NIR-absorbing property of polypyrrole to track both
the nanoparticle separately from its NIR-fluorescent cargo. Utilizing the absorbing
properties of the PPy-CS which contained an IR-780 cargo, multispectral optoacoustic
tracking of phantom-based models revealed that both polypyrrole and IR-780 were
separately identified indicating both the presence of the nanomaterial and cargo dye.

SUMMARY:

In this study, a nanoparticle was developed to serve as means to enhance the
detection of ovarian cancer tumor cells in vitro. A unique feature of this nanoparticle was
its ability to actively target the acidic microenvironment found in the extracellular matrix of
all tumor cells. The nanoparticle was synthesized by utilizing a polymer-base and then
encapsulated with chitosan and the modified targeting peptide.

A series of

characterization studies and assays were conducted to determine the effectiveness of the
nanoparticle.

Characterization studies demonstrated the nanoparticle displayed an

appropriate size of approximately 50 nm. This size is small enough to not be detected by
macrophage in the liver and large enough not to be effluxed out of the vasculature of the
tumor microenvironment. Assays demonstrated the nanoparticle’s ability to maintain its
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cargo and actively target tumor environments with minimal off-targeting. The nanoparticle
was placed in an optoacoustic tomographic imaging system to determine its ability to be
tracked by the imaging system. The nanoparticle displayed signaling within the imaging
system both with the infrared dye and alone.

1. INTRODUCTION

In the United States, ovarian cancer is the fifth leading cause of cancer-related
deaths among women. Although only affecting approximately 1 out every 75 women, the
5-year survival rate is only approximately 17%. The reason for this rather low survival rate
is due to the lack of earlier detection of ovarian cancer. Most women who are diagnosed
with ovarian cancer are being diagnosed in later stages (III and IV) rather than the earlier
stages (I and II), where treatment is much more beneficial and effective. The current
imaging modalities utilized are those such as magnetic resonance imaging (MRI),
computed tomography (CT), and positron emission tomography (PET). The lack of earlier
detection stems from the inability for most imaging modalities to differentiate the presence
of early stage ovarian tumors.

The current method of treatment consists of rounds of chemotherapy focused
around the Enhanced Permeability Retention (EPR) effect.

The EPR effect is the

phenomenon in which molecules of certain molecules circulate through the body and
eventually accumulate in tumor tissues much more so than in non-malignant areas.
However, there are limitations to the effectiveness of this method of treatment. Most
chemotherapeutics are highly cytotoxic, compounds harmful to living cells, and display
harmful effects to non-malignant areas. Due to the problems current methods have faced,
alternative treatment options have been developed to provide patients with better care.
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The use of nanovehicles, targeting nanoparticles containing specified cargo, as a
possible contrasting agent has shown great promise in substantially improving the
detection and treatment of cancer [1, 2]. However, there still remain underlying problems
and limitations to their effectiveness.

The development of novel metallic-based

nanovehicles utilizing receptor-targeting mechanisms has been extensively studied, due
in part to the ability to track these metallic nanoparticles by means of nuclear imaging
modalities and more recently optoacoustic imaging [3]. Unfortunately, the majority of
metal components (Fe, Zn, Cu, Ti, Co, etc.) found in these nanoparticles exhibit some
level of cytotoxicity. More specifically, the nanosized particles of these metal-oxides have
recently shown to be toxic to some organisms [4]. Therefore, the use of polymer-based
nanoparticles has garnered much attention as a possible theranostic tool in the treatment
of cancer [5]. This interest is due to the low-cytotoxicity, controllable permeability, and
surface functionality inherently found in polymer-based hollow nanospheres [6-8].

However, polymer-based nanoparticles themselves have encountered obstacles
which have resulted in its further development as well. Difficulties in tracking polymerbased nanoparticles result from a general requirement of additional contrast dyes, radiolabels,

or

other

tracking

moieties

to

determine

in

vivo

biodistribution

and

accumulation. With this in mind, a traceable compound, pyrrole, was selected to provide
an encapsulation coat for cargo.

Uniquely, polypyrrole polymers display an inherent

absorbing property in which the pyrrole absorbs at the higher level of the spectrum,
approximately 980 nm [9]. This inherent emittance of signal, by the pyrrole nanoparticle,
allows for enhanced levels of tracking of the nanocontrasting agent, while in vivo with the
use of optoacoustic tomography. Nanocontrasting agents serve as vehicles which contain
contrast agents, such as dyes, that allow for better detection by an imaging modality. This
polypyrrole chitosan-coated hollow nanosphere (PPy-CS Hollow Nanosphere) is unique
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in the fact that it emits a photoacoustic signal without the aid of an additional NIR-dye
cargo. From the research we have conducted, contemporary nanoparticles do not display
any detectable absorbance properties which would allow for such enhanced
detection. This nanoparticle, in unison with the emerging modality of optoacoustic
imaging, can address many of the shortcomings of current diagnosis methods as well as
enhance targeted drug delivery to tumor cells.

Currently, nuclear imaging is the foremost imaging modality used in terms of noninvasive in-situ imaging of biological tissues and materials. However, with the need for
further improvement of image resolution and quality, optoacoustic imaging has emerged
as a promising novel biomedical imaging modality [10, 11]. Unlike nuclear imaging,
optoacoustic imaging does not solely utilize radio-labels and radioactive material [12] as
a means to trace a contrasting agent, rather it emits light energy which then reflects off of
the contrast agent and produces a sound wave which is then recorded by an ultrasonic
transducer allowing for an ultrasound image with higher resolution [13-16].

Multispectral optoacoustic tomography (MSOT) combines the benefits of
enhanced sensitivity found in optical imaging and the depth of detection that is usually
associated with ultrasound [17]. The ability for detection without the need for application
of radiation is a significant benefit due to the damaging side-effects associated with
prolonged exposure to radiation [18, 19]. An advantage of MSOT imaging also includes
its ability to compile molecular and functional information, with high spatial resolution, in
real-time. Also, it is able to distinguish various contrasting agents already present within
the tissue, e.g. hemoglobin [16, 18]. Due to optoacoustic imaging’s ability to detect
absorbing molecules at depth, it provides a means of detection for absorbing nanoparticles
which would allow for determination of the overall accumulation and biodistribution in real
time. In current mice models, this process occurs over a process of hours until the
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nanoparticles are able to completely reach the tumor microenvironment. The advantages
of optoacoustic imaging capabilities provide essential features including less exposure to
radiation, rendering of more in-depth imaging, and a lesser invasive procedure than that
of current modalities. Therein lies the need for the further development of enhanced tumor
targeting agents [20-24].

In order for nanovehicles to be effective in the clinic, the nanovehicle must have:
1) increased tumor-specific accumulation and reduced off-target binding, and 2) increased
signal/payload within tumors than compared to current diagnostic or therapeutic
agents While additional biological barriers, e.g. poor vascularity [25] and presence of
stroma [26], associated with recalcitrant tumors present additional challenges for
development of nanovehicles, these recalcitrant tumors also offer the potential for high
clinical impact for theranostic agents. Tumor-environments display various hallmark
features which include acidic extracellular pH [27], increased levels of hypoxia [28],
presence of autoantibodies [29] etc. With this in mind, we exploited the presence of acidic
pH in the extracellular matrix of tumor cells as a general feature that would not be present
in non-malignant tissue. In the clinic, tumors have acidic pHe (6.4–6.8) compared to nonmalignant tissue (pHe 7.2-7.4) [30]; however, this small difference in extracellular pH alters
the function, metastatic potential, and survival of tumor cells. To exploit the acidic
extracellular pH as a targeting strategy for our polypyrrole nanocontrasting agent, we
utilized a V7 pHLIP (pH Low Insertion Peptide), which changes conformation in response
to its environment. In neutral pHe (7.2-7.4), it maintains a globular form and transforms to
a transmembrane alpha-helix at acidic pHe conditions (6.4-6.8), this then allows the
conjugated particle to insert and anchor into tumor cells [31-33].

pHLIPs are a specialized group of peptides derived from the bacteriorhodopsin C
helix which maintain water solubility and semi-hydrophobicity. In neutral or higher pH
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levels, the pHLIP is monomeric, remains non-reactive, and retains an unstructured or
globular form. However, when placed in an acidic environment, it leads to the protonation
of negatively charged residues on the helical segment and results in a shift in equilibrium,
ultimately forming the alpha-helix structure [31]. Multiple studies have been successfully
conducted with the use of pHLIPS as an additional modifier to existing polymer-based
nanoparticles for pH-sensitive in vivo targeting for delivery as well as imaging [34, 35].

Recently, several types of ligand based probes and inorganic nanoparticles have
been detected using optoacoustic imaging for improved cancer detection in glioma, breast,
and pancreatic cancers [36]. Near-infrared(NIR) fluorescent dyes conjugated to tumor
targeted ligands and gold nanomaterials (including nanorods, and gold composite
nanostructures) are likely the most-widely explored exogenous contrast agents for
optoacoustic imaging. A number of other inorganic nanomaterials, including gold and
silver nanoparticles, have also demonstrated tumor specificity [6, 37], albeit often in
subcutaneous tumors. However, the majority of inorganic nanoparticles have high uptake
in the MPS system and may remain in the subject for long periods of time without the
potential of degradation. This is a serious problem for the development of nanocontrasting
agents for clinical use as patients often will receive multiple doses over time to determine
tumor response, progression, and potentially even local metastasis. Therefore, the use of
NIR absorbing organic nanoparticles offers a substantial improvement as nanocontrasting
agents detectable by optoacoustic imaging.

In this study, I synthesized, modified, and evaluated an acidic extracellular pHtargeting polypyrrole chitosan-coated hollow nanosphere as a tumor targeting
nanocontrasting agent detectable by multispectral optoacoustic tomography [38,
39]. With the addition of the V7 ligand to the PPy-CS, the nanoparticle displayed
enhanced targeting capabilities in vitro. To the extent of my knowledge, this is the first
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recorded tracking of a polymer-based nanoparticle through optoacoustic imaging in any
ovarian cancer cell line, without the use of an additional contrasting agent. This
nanoparticle is unique in the fact that the polypyrrole-coating provides an enhanced
spectrum of detection through its inherent absorbance in the infrared region. The
incorporation of this nanoparticle and fluorescent dye has proved to be a successful
contrast agent and displays great promise for possible future use as a nanovehicle for
chemotherapeutics.

2. RESULTS AND DISCUSSION

2.1 Particle Synthesis and Characterization

The schematic seen in Figure 1 displays the experimental method which was used
to synthesize the PPy-CS. From transmission electron microscopy (TEM) analysis (Figure
1B), we were able to confirm the successful removal of the AgCl cores as well as the
desired relatively small-size of 43.56 ± 9 nm in diameter with a pore-size of 15 ± 6 nm
(This size is approximately equivalent to the eye-lash of Abraham Lincoln on the penny).
Nanoparticles with a size greater than 100 nm tend to be too large and would eventually
be filtered out by macrophage found in the liver or kidneys [40]. Therefore, particle size
control played a crucial part during the synthesis of these particles.
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Figure 1:

Additionally, particle size was confirmed with the use of dynamic light scattering
(DLS) [41]. Figure 2 displays the DLS measurement of the PPy-CS maintaining a particle
size of 51.39 nm. This measurement was slightly larger than the desired range of less
than 50 nm; however, it remained consistent with the readings from the TEM images. This
desired size was obtained through a series of dialysis in ammonium hydroxide and
modified measurements of the initial substrates to form the silver-chloride core.

Figure 2:

Zeta potential was incorporated to measure the change in voltage exhibited by the
nanosphere [42]. Zeta potential is utilized in determining the potential difference between
a solid surface of a particle and its conducting solvent. This technique was used to help
determine the expansion of the chitosan-coat in the presence of acidic pH and to ensure
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encapsulation in the presence of more neutral pH. The zeta potential of the nanospheres
in various pH displayed a difference of -12.4 to -9.6 (Figure 3). An increase in voltage was
seen as the corresponding pH decreased [43, 44].

As pH decreased, the

attraction/stability between the pyrrole-coating and chitosan increased and resulted in
enhanced binding with regards to pH-specificity. These results confirmed the formation of
the nanosphere with a functional chitosan-coat.

Figure 3:

The absorbance properties displayed by the PPy-CS, alone, allowed for detection
using MSOT without the aid of a dye or any other indicator. This inherent absorbance
signal provides a significant advantage to the further development of tumor-targeting
nanocontrasting agents. To the best of our knowledge, we believe this is the first study
that depicts the tracking ability of a polymer particle without the aid of an additional
contrasting agent by means of optoacoustic imaging. With the aid of the MSOT system,
we were able to determine that the synthesized nanosphere displayed its own unique
absorbance signal which was distinguishable from the IR-780 dye (Figure 4). The pyrrole,
alone, emitted a signal greater than 800 nm and extended onward, while the PPy-CS
hollow nanospheres emitted a peak at 710 nm (Figure 5).
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Figure 4:

Figure 5:

With increased ability to ascertain the biodistribution of the nanospheres and dye
separately, we were better able to track the efficiency of the nanoparticle’s tumor-targeting
capabilities. The development of a nanocontrasting agent with the ability for detection,
without the limitation of a dye, enables for enhanced detection as well as further insight in
the trajectory and effectiveness of delivery of chemotherapeutics. This unique property
may prove to be a strategic indicator in future studies and possibly minimize
inexact/inconclusive signaling.
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2.2 Determination of pH specificity of V7-conjugated PPy-CS hollow nanospheres in vitro

Two ovarian cancer cell lines, ES-2 and A2780, were utilized to determine cellular
uptake of the nanoparticles. ES-2 cell lines are an aggressive cell line and are typical in
patients who are diagnosed with later stage ovarian cancer. A2780 cell lines are not as
aggressive, but are a type found in many patients diagnosed with ovarian cancer as well.
The nanoparticle, containing IR-780 dye, was introduced to both cell lines and placed on
a rocker in a non-CO2 incubator to allow for distribution of the particle throughout the well.
A non-CO2 incubator was utilized in order to prevent possible changes in the pH of the
media, if it were to interact with carbon-dioxide. The plates were then placed on odyssey
infrared imaging to determine uptake of the nanoparticles in the cells.

For both cell lines,

greater uptake was observed in the more acidic environments, pH 6.6, compared to those
in neutral, pH 7.4. For the A2780 cell line, binding was approximately 9.3 times greater
for the corresponding pH levels. For the ES-2 cell line, binding was approximately 7 times
greater in pH 6.6 compared to 7.4. (Figure 6).

Figure 6:
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Figure 6:

B

Tissue-phantoms were used to further test the pH-specificity of the dye-conjugated
PPy-CS. Two separate conjugation processes were used to determine which displayed
a greater level of binding, with regards to acidic pH. (3-Aminopropyl) triethoxysilane
(APTES) is utilized as a cross-linker, which aids in the binding of the peptide-linker, 4-(NMaleimidomethyl)cyclohexanecarboxylic acid N-hydroxysuccinimide ester (SMCC) to the
surface of the nanoparticle. APTES is needed in order to fully conjugate the V7-peptide to
the nanoparticle. The introduction of APTES in the early conjugation process displayed
3.5 times greater binding intensity at pH 6.6 compared to pH7.4. This earlier addition
occurred after the encapsulation of the dye. The later addition occurred after the addition
of SMCC. However, the addition of APTES at the later stages of conjugation displayed
9.4 times greater binding intensity for the corresponding pH (Figure 7).

This variation in

APTES addition may display the role of the linker as a more efficient intermediary agent
for the addition of SMCC compared to its role in the conjugation of chitosan.
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Figure 7:

2.3 Cellular uptake of PPy-CS

To further determine the pH specificity of the PPy-CS, fluorescence microscopy
was performed to verify whether or not the PPy-CS were truly being anchored into the
tumor cells [45].

Propidium iodide was utilized as the contrasting agent.

Because

Propidium iodide is not a cell permeable dye, it was encapsulated into the nanospheres in
order to monitor the intracellular uptake and dye release in conjunction with acidic
pHe. The fluorescence of red compared to green confirmed whether cellular uptake or
accumulation on the surface was taking place.

2.4 Dye-Release Assessment of Cargo-Carrying Capability

PPy-CS loaded with IR-780 dye were evaluated for pH-specific dye release. The
dye-conjugated nanoparticles were introduced into phosphate buffer saline (PBS)
solutions of pH 6.6, 6.9, or 7.4. The PPy-CS in PBS solution of pH 6.6 were found to have
released ~1.7 times greater the amount of IR-780 dye compared to those in PBS solution
of pH 6.9 and 7.4 (Figure 8). It was determined that the level of absorbance directly
correlated with the amount of IR-780 dye that had been released from the PPy-CS [46].
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This contrast in dye release illustrates the preferential release of cargo displayed by the
PPy-CS. From these dye-release kinetics, it can be inferred that introduction of the
nanospheres in vivo will result in targeted release of cargo to the tumor-region and limited
off-targeting to non-malignant tissue. In a clinical setting, the nanovehcles, containing the
infrared dye, is detected with a handheld scanner and the image is then seen on the
optoacoustic system. This provides a less-invasive and more accessible method of
imaging than compared to current methods.

Figure 8:

The pyrrole-coating provided a flexible structure which allowed for the nanosphere
to better conform to its surroundings [47]. The PPy-CS were better-equipped to adapt to
the change from neutral pH to more acidic pH without fracturing the overall integrity of the
structure and pre-maturely releasing its cargo. The chitosan-coating expanded, in the
presence of acidic pH, and released the dye. However, in the presence of neutral pH, the
chitosan-coating would remain intact and continue to encapsulate the dye. This specified
targeting and specified release helped to prevent off-targeting. The PPy-CS, carrying dye,
required a rate of release that was not immediate and random, but discharged at a rate in
which a majority of the dye was gradually released in the tumor-region.
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3. CONCLUSION

In this study, pyrrole exhibited inherent absorbance properties which allowed it to
be detected without the aid of a contrasting dye. This distinction would allow for a more
precise tracking of the targeted nanosphere in vivo. With pyrrole serving as the principal
encapsulating vehicle, a hollow nanosphere with a dual pH-specific mechanism was
developed using a silver-chloride core template with pyrrole and chitosan-coating. It was
then conjugated with a specifically designed pH-specific reactive ligand to allow for tumortargeting. Conjugated PPy-CS displayed active tumor-targeting capabilities in in vitro
studies with limited off-targeted binding. The use of a pyrrole-based nanoparticle
incorporated with fluorescent dye has presented itself as a novel nanocontrasting
agent. The nanoparticle demonstrated a sufficient size of ≈ 44 nm with a pore size of ≈
15 nm.

This target size allows for efficient uptake by tumor cells without the

disadvantageous side-effects of larger particles such as targeting by macrophage in the
kidneys. These dimensions are most suitable for transport and navigation towards the
tumor cells once intravenously introduced.

Using various imaging modalities, we further evaluated the biodistribution and
tracking of the PPy-CS and established that the nanospheres exhibited amplified signaling
and pH specificity. This unique inherent absorbance displayed by the PPy-CS allowed for
enhanced detection of the nanosphere by the imaging system. The inherent absorbance
provided an individual spectrum which allowed for a distinction between the actual
nanoparticle and the location of the IR-780 dye. Being able to distinguish the location of
the separate components allowed for a more accurate interpretation of the effectiveness
that the nanoparticle would display in locating the desired tumor-region.
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In future studies, the PPy-CS will be functionalized to serve as nanocarriers for
chemotherapeutics

due

to

its

unique

tracking

capabilities

in

photoacoustic

imaging. Additional modifications will be made to the nanoparticle to develop it as a
radiosensitizer to allow for enhanced treatment in radiation therapy. The further
elaboration of this study provides great potential toward the development of a theranostic
agent for clinical applications.

4. EXPERIMENTAL SECTION

Materials: Silver Nitrate (AgNO3), Pyrrole, Chitosan, Iron (III) Chloride (FeCl3), (3aminopropyl) triethoxysilane (APTES), 4-(N-Maleimidomethyl)cyclohexanecarboxylic acid
N-hydroxysuccinimide ester (SMCC)( ≥98%, powder), Dialysis Tubing benzoylated,
Ammonium Hydroxide (NH4OH), Nitric Acid (HNO3) were purchased from (Sigma-Aldrich,
St. Louis, MO) and used as received. Dulbecco’s Modified Eagle’s Medium (DMEM), Lglutamine, and RPMI medium were purchased from Life Technologies (Grand Island, NY).
Fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA) and the V7 ligand (Cisbio,
Bedford, MA) were used as received.

Characterizations: The UV-vis absorption spectra were recorded with both MSOT and a
Thermo-Scientific Model NanoDrop 2000 spectrophotometer. TEM images were obtained
using a Tecnai-F20. Each TEM sample was prepared by dropping 50 µL of nanoparticle
solution (in Milli-Q) on to copper-mesh grids (Electron Microscopy Science, Hatfield, PA)
and they were then allowed to dry in room temperature overnight before imaging. For
zeta-potential, the samples were measured by a Zetasizer Nano-ZS (Malvern Instruments
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Ltd.) at room temperature. Smoluchowski’s equation was used to determine the
electrophoretic mobility (µE) of the sample:

The ζ stands for the zeta-potential, ε the existing permittivity of the solvent, and η the
viscosity of solvent. The same Zetasizer Nano-ZS (Malvern Instruments Ltd.) was used to
measure size distribution for Dynamic Light Scattering (DLS).

Preparation of Materials: Stir bars, spatulas, and beakers were cleaned and thoroughly
rinsed with DI water and Ethanol, and were then placed in autoclave. Materials were
allowed to cool before any reactants were added.

Synthesis of AgCl Core Solution: The additions and polymerizations of this preparation
step occurred in a 5° C environment. 0.003g of AgNO3 and 0.0083 mL of pyrrole were
added to a 6.7 mL chitosan solution (1% weight in 0.05 M HNO3). 0.047g of FeCl3 was
dissolved in 5 mL of Milli-Q water and the dispersion was then introduced to the chitosan
solution. The resulting solution was polymerized for 12hrs. Once polymerization was
completed, dialysis tubing was utilized to remove impurities from the mixture. Dialysis
tubing was placed in a 0.05 M HNO3 solution for an additional 12 hrs. Lastly, the AgCl
core-shell material was obtained by a series of precipitation with acetone and
centrifugation (4000 RPM for 25 min). Once the supernatant was removed, the precipitate
was placed in a vacuum for 12 hrs at room temperature. The resulting product formed
was the AgCl core-shell material.
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Synthesis of PPy Hollow Nanosphere: A 0.005g portion of the AgCl core-shell material
was dispersed in 20 mL of Milli-Q water by a combination of vortex and
ultrasonication. The pH of the solution was adjusted to 12 by drop-wise addition of 5M
NH4OH and then stirred for 24 hrs in a 5° C environment. Dialysis tubing was used to
remove the formed silver ammonia ions. This removal process occurred in a 0.1M NH4OH
solution. Once dialysis was completed, the pH of the solution was adjusted down to 4 with
the drop-wise addition of 2M HNO3. Finally, the PPy hollow nanospheres were obtained
by a series of precipitation with acetone and centrifugation (4000 RPM for 30 min). Once
the supernatant was removed, the precipitate was placed in a vacuum for 12 hrs at room
temperature. The resulting product formed was the PPy hollow nanospheres.

Conjugation of V7-Ligand to PPy-CS Hollow Nanosphere: 0.0025 g of the solid PPy-CS
material was obtained and placed in an Eppendorf tube containing 1 mL of phosphate
buffer solution (PBS) containing a pH of 7.4. This solution was then dispersed by a series
of vortex and ultrasonication. From the solution, 300 µL were placed in a separate
Eppendorf tube and 30 µL of APTES were added and the mixture was vortexed for 30
min. Once finished, the pH of the solution was reduced down to 3.8 and 30 µL of IR-780
dye was introduced. The solution was then vortexed for 20 min. After this second round
of vortex, the pH of the solution was readjusted back up to 7.4 with the drop-wise addition
of NaOH and this resulting mixture was placed on vortex for 10 min. Next, 50 µL of SMCC
(15 mM, 0.005014g in 1mL of DMF) was introduced to the solution and immediately after
50 µ of the V7-ligand (0.005g in 300 µL of DMF) was added as well. The Eppendorf was
then vortexed for 12 hrs.

Cell Culture: The ovarian cell lines A2780 and ES-2 were cultured in DMEM medium (Life
Technologies) with 10% FBS (Atlanta Biologicals) and 1% L-Glutamine (Life
Technologies) at 37° C in a humidified atmosphere of 5% CO2.
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In Vitro Infrared Imaging to Determine pH-specificity: A2780 and ES-2 cells were placed
in 6-well plates at a density of 500,000 cells per well. The 2 separate rows contained
varying pH- media. One contained a pH of 6.6, whereas the other maintained a pH of
7.4.

After 24 hrs of incubation at 37° C and non-CO2, 50 µL of V7-conjugated PPy-CS

hollow nanosphere (22.85 µM) was introduced to two of the columns for the A2780 and
the ES-2 cells. The last column served as a control group. The cell-plates were placed
on a rocker in the non-CO2 incubator for 20 min; it was then placed on the Odyssey (LICOR Biosciences) to determine if there was signaling present. Once signaling was
detected, the cell-plates were washed with the corresponding phosphate buffer solution
(PBS) and then placed back in to non-CO2 incubator for an additional 20 min. The need
for placement in a non-CO2 environment stemmed from the desire to prevent sidereactions between the pH-specified phosphate buffer and the environmental carbondioxide. This process was repeated 3 times until optimal pH-specific signaling was
achieved. Dosimetry analysis of IR-780 dye was conducted using Image-J software.

Optoacoustic Imaging of Tissue Phantoms: Tissue Phantoms (A mixture of agar and lipid
used to mimic living tissue) provide an ideal model in allowing for comparable density and
size found in mice. This model of imaging allows for an indicator of possible success in
vivo. ES-2 cells were placed into 6-well plates for 24 hrs in DMEM media. After
completion, the media were removed, pH-specific media were then applied and the cells
were incubated for 4 hrs at 37°C in non-CO2. The PPy-CS hollow nanospheres (50 µL)
were then added to the wells and rocked in the incubator for an additional 2 hrs. Next, the
cells underwent a series of 3 washes with specified PBS of pH 6.6 and 7.4 to each row.
The cells were then scraped from each well and were collected in 1 mL of the
corresponding PBS. Tissue phantoms were constructed with the use of Agar (Sigma
Aldrich, St. Louis, MO), intralipid (Sigma Aldrich, St. Louis, MO), and DI water.
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Figure Legend
Figure 1: A.) The silver-core portrayed by the silver circle is enclosed by a chitosan-coat
depicted with the porous blue sphere. At pH of 6.6, V7 ligand became active and
dye release was present. The protruding red-lines represent the active V7 ligand
and the smaller circles depict cargo-release. At pH of 7.4, dye release was much
less significant.
B.)
Transmission Electron Microscopy (TEM) images
demonstrate the successful removal of the AgCl core to form the PPy-CS hollow
nanospheres. The TEM images display the diameter of the PPy-CS hollow
nanospheres as 43.56 + 9 nm with a pore size of 15 + 6 nm
Figure 2: Dynamic Light Scattering (DLS) measurement of PPy-CS hollow nanospheres
demonstrate a size of 51.39 nm. This size is within the range depicted from the
TEM imaging.
Figure 3: The conjugation of PPy-CS hollow nanospheres with chitosan. Zeta Potential
confirms the presence of chitosan on the nanoparticle. This can be seen with the
increase in pH with the corresponding decrease in voltage. This correlation is the
result of lessened protonation on the chitosan coated PPy-CS hollow nanospheres
Figure 4: Multispectral optoacoustic tomographic (MSOT) image of the conjugated PPyCS hollow nanosphere in phantom tissue displays distinct absorbance spectrum
detected by MSOT system.
Figure 5: The absorbance spectrum for the PPy-CS hollow nanosphere was obtained.
From phantom imaging, the pyrrole present in the particle exhibited a signal on its
own without the aid of IR-780 dye.
Figure 6: A.) Odyssey Infrared Imaging displays distinct in-vitro cellular uptake in acidic
cellular environment, pH 6.6, compared to that of pH7.4. B.) Odyssey images
display a significant difference in the level of intensity of signal that was present
between the PPy-CS hollow nanospheres in pH of 7.4 compared to that of pH 6.6.
Figure 7: During tissue phantom imaging, two samples were used to determine which
procedure, for the addition of APTES, provided the greatest difference in signal
between pH of 7.4 and 6.6. Both particle samples resulted in a difference in the
signal intensity. However, the addition of APTES before the conjugation of SMCC
and V7 displayed a greater difference in signal intensity compared to the addition
of APTES along with the initial PPy-CS hollow nanospheres. APTES (First)
displayed a difference of approximately 7 times more intensity for pH 6.6 compared
to 7.4. APTES (Later) displayed a difference of approximately 9.4 times more
intensity for pH 6.6 compared to 7.4.
Figure 8: PPy-CS hollow nanospheres loaded with IR-780 dye were evaluated for pHspecific dye release. The dye-conjugated nanoparticles were introduced into
phosphate buffer saline (PBS) solutions of pH 6.6, 6.9, or 7.4. The absorbance
level of each solution was measured by UV-Vis spectroscopy over a 10 hour period.
It was determined that the level of absorbance directly correlated with the amount
of IR-780 dye that had been released from the PPy-CS hollow nanospheres. The
PPy-CS hollow nanospheres in PBS solution of pH 6.6 were found to have
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released ~1.7 times greater the amount of IR-780 dye compared to those in PBS
solution of pH 6.9 and 7.4. This contrast in dye release illustrates the effective pHspecificity found in the PPy-CS hollow nanospheres.

